CClinicalTrials.gg
CompletedNCT06662682Updated Feb 3, 2025

Effects of Whole-Body Vibration in Patients with Knee Osteoarthritis.

An interventional study of Whole-Body Vibration and Control Condition in Knee Osteoarthristis, sponsored by University of Erlangen-Nürnberg Medical School. Completed at 1 site in Germany. Open to participants aged 40 Years to 75 Years. Per ClinicalTrials.gov, last updated 2025-02-03.

Sponsored by University of Erlangen-Nürnberg Medical School · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jul 2024, registered Oct 2024).
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
40 Years to 75 Years
Sex
All
01

Study summary

Knee osteoarthritis is a chronic joint disease with an impact on quality of life and an increasing incidence what leads to huge costs and burden on the economy.

The present study investigates immediate effects of whole-body vibration on pain, neuromuscular performance, and gait quality in patients with knee osteoarthritis. Eligible patients (n=20) with knee osteoarthritis grade 2 or 3 on Kallgren Lawrence will complete a 5 minute WBV training and a control condition in a randomized order (cross over design). Pain, maximum strength of the leg flexors and extensors, the chair rise test and gait parameters will be measured directly before and after the intervention/control.

02

Conditions studied

  • Knee Osteoarthristis

Keywords

  • Knee OA
  • whole-body vibration
  • pain
  • physical function
  • gait parameters
03

In context

Osteoarthritis

4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.

This study's enrollment of 20 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.

Browse Osteoarthritis studies →

Lead sponsor

University of Erlangen-Nürnberg Medical School is the lead sponsor of 267 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • x-ray confirmed knee osteoarthritis (Kallgren-Lawrence 2-3)
  • knee pain (NRS 0-10 \>2) for 3 months and at least 50% of the last 30 days

Exclusion criteria

Exclusion Criteria:

  • contraindications for WBV (acute injuries of the musculoskeletal system, new joint endoprosthesis, pregnancy, acute thrombosis, Epilepsia, cholecystolithiasis, nephrolithiasis, heart pace maker),
  • other pathologies affecting gait or neuromuscular performance (rheumatic
  • opioid medications, cortisol medications and intraarticular injections in the knee during the ist 3 months.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Whole-Body Vibration

    The intervention (IC) will be specified as a five-minute Whole-Body Vibration session.

    Other: Whole-Body Vibration

  • Other
    Control Condition

    The control condition (CC) will conduct the same protocol as the intervention condition. The only difference will be that the vibration plate will be switched off.

    Other: Control Condition

Interventions

  • OtherWhole-Body Vibration

    The intervention (IC) will be specified as a five-minute Whole-Body Vibration session. The WBV take place on a side alternating vibration plate (Wellengang, Germany). The patients stand barefoot on the vibration plate on a prescribed position. In this position the amplitude will be 6-7mm. The WBV protocol contains mobilizing sequences with lower frequencies and activating sequences with higher frequencies

  • OtherControl Condition

    Non-intervention control condition

06

What researchers measure

Primary outcomes

  1. Changes in pain of the osteo-arthrotic knee

    Changes in pain of the osteo-arthrotic knee during the treadmill test as determined on a visual analogue scale (VAS 0-10).

    Time frame: Changes in pain of the osteoarthrotic knee during the treadmill test as determined on a visual analogue scale (VAS 0-10) before and after 5 min of intervention

Secondary outcomes

  1. Changes in isometric maximum leg flexion strength of the osteoarthritis knee

    Changes in isometric maximum leg flexion strength of the osteoarthritis knee as determined by dynamometer (easy torque, Tonus, Germany)

    Time frame: Changes in isometric maximum leg flexion strength of the osteoarthritis knee before and after 5 min of Intervention.

  2. Changes in isometric maximum leg extension strength of the osteoarthritis knee

    Changes in isometric maximum leg extension strength of the osteoarthritis knee as determined by dynamometer (easy torque, Tonus, Germany)

    Time frame: Changes in isometric maximum leg extension strength of the osteoarthritis knee before and after 5 min of Intervention

  3. Changes of number of repetitions in the 30 s sit to stand (chair rise) test

    Changes in number of repetitions in the 30 s sit-to-stand test as suggested by Guralnik et al.

    Time frame: Changes in number of repetitions in the 30 s sit-to-stand test before and after 5 min of intervention

  4. Changes of ipsilateral stride length

    Changes of ipsilateral stride length (cm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany)

    Time frame: Changes of ipsilateral stride length (cm) at treadmill as determined by the 4D motion high-performance lab ( (Firma Diers Formetric, Germany) before and after 5 min of Intervention

  5. Changes of ipsilateral stride time

    Changes of ipsilateral stride length (cm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany)

    Time frame: Changes of ipsilateral stride length (cm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention.

  6. Changes of stride width

    Changes of stride width (cm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany)

    Time frame: Changes of stride width (cm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention.

  7. Changes of ipsilateral stance time

    Changes of ipsilateral stance time (%) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany)

    Time frame: Changes of ipsilateral stance time (%) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention

  8. Changes of ipsilateral single support time

    Changes of ipsilateral single support time (%) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany)

    Time frame: Changes of ipsilateral single support time (%) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention

  9. Changes of double support time

    Changes of double support time (%) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany)

    Time frame: Changes of double support time (%) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention

  10. Changes of trunk inclination

    Changes of trunk inclination (mm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany)

    Time frame: Changes of trunk inclination (mm) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention

  11. Changes of ipsilateral und kontralateral knee angle in frontal plane

    Changes of ipsilateral und kontralateral knee angle (°) in frontal plane at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany)

    Time frame: Changes of ipsilateral und kontralateral knee angle (°) in frontal plane at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention

  12. Changes of ipsilateral und kontralateral knee angle in sagital plane

    Changes of ipsilateral und kontralateral knee angle in sagital plane (°) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany)

    Time frame: Changes of ipsilateral und kontralateral knee angle in sagital plane (°) at treadmill as determined by the 4D motion high-performance lab (Firma Diers Formetric, Germany) before and after 5 min of intervention

07

Study locations

1 site
  • Oniversity Hospital Erlangen
    Erlangen, Bavaria 91054, Germany
08

References and documents

Publications

  • von Stengel S, Kemmler W, Engelke K, Kalender WA. Effect of whole-body vibration on neuromuscular performance and body composition for females 65 years and older: a randomized-controlled trial. Scand J Med Sci Sports. 2012 Feb;22(1):119-27. doi: 10.1111/j.1600-0838.2010.01126.x. Epub 2010 May 24. PubMed 20500555 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06662682
Lead sponsor
University of Erlangen-Nürnberg Medical School
Responsible party
Wolfgang Kemmler, PhD (Head of Research, Friedrich-Alexander-Universität Erlangen-Nürnberg) — Principal investigator
First posted
Oct 29, 2024
Start date
Jul 15, 2024
Primary completion
Jan 15, 2025
Completion
Jan 16, 2025
Last update
Feb 3, 2025

Study contacts

Marcel Betsch, MD
study director · University Hospital Erlangen, Germany

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion